Web28-day Field Effectiveness Study Safety was evaluated in a 28-day field study in 288 cats (192 SEMINTRA group cats, 96 control group cats) that received at least one dose of study drug. The control product was a vehicle control without telmisartan. Cats enrolled in the study had a median age of 14 years (7-20 years), and weighed 1.93-11.4 kg. WebBurlington, ON June 2, 2014– A new treatment option for cats diagnosed with chronic kidney disease has been launched in Canada by Boehringer Ingelheim (Canada) Ltd. Semintra ® is the first ever angiotensin receptor blocker to receive marketing authorization in veterinary medicine, and contains the active ingredient telmisartan. It is licensed for the reduction of …
Semintra 4 mg/ml oral solution for cats (GB) - NOAH Compendium
WebSEMINTRA is an angiotensin II antagonist/angiotensin receptor blocker (ARB). Pregnant women should avoid contact with SEMINTRA because substances that act on the renin … WebSemintra is not to be given to patients with cholestasis, biliary obstructive disorders or severe hepatic impairment since telmisartan is mostly eliminated with the bile. These patients can be expected to have reduced hepatic clearance for telmisartan. Semintra should be used only with caution in patients with mild to moderate hepatic impairment. ar tia pmp
10 mg/mL - SEMINTRA
WebSemintra- ein Tierarzneimittel für Katzen zur Reduzierung der Proteinurie und zur Behandlung von hohem Blutdruck. Jetzt sparen mit medizinfuchs.de Preisvergleich für … WebJul 31, 2014 · Semintra [emoji]174 [/emoji] is the first ever angiotensin receptor blocker to receive a marketing authorisation in veterinary medicine, and contains the active ingredient telmisartan1. It is licensed for the reduction of proteinuria (i.e. the unwanted loss of proteins via the urine) associated with chronic kidney disease (CKD) in cats. WebWirkstoff: Telmisartan 1 ml Semintra 10 mg/ml orale Lösung enthält: Telmisartanum 10 mg. Hilfsstoffe: Conserv.: Benzalkonii chloridum, Aromatica, excip. pro sol. Wissenschaftliche Hintergrunddaten (CliniPharm Wirkstoffdaten) Telmisartan Eigenschaften / Wirkungen arti aplikasi menurut para ahli